Description
ELSEVIER Claytons Basic Pharmacology For Nurses With Access Code 19Ed (Pb 2022) by WILLIHNGANZ M.J.
Today's patients have unique cardiological needs before, during, and after cancer treatment. Chemotherapies, radiation therapy, and targeted therapies can produce side effects or lasting adverse consequences on the heart and circulatory system, making the field of cardio-oncology increasingly important in today's health care. Cardio-Oncology Practice Manual is a comprehensive, portable guide that provides practical approaches to assessment and management of cardiovascular disease due to the effects of cardiotoxic agents and treatments. Part of the Braunwald family of renowned cardiology references, it clearly presents clinically-relevant aspects of this growing field in one quick, practical reference for a wide range of cardio-oncology providers.Covers all major cancer therapies, cardiovascular toxicities, and malignancies in a portable, authoritative guide-ideal for cardiologists, cardio-oncologists, general practitioners, internists, medical oncologists, and hematologists.Offers templated and streamlined content for quick retrieval, with key point summaries for each major section.Presents cardiac disease entities and specific malignant diseases in a succinct overview format addressing important clinical care aspects.Features "Central Illustrations" for each topic that visually summarize the chapter and its specific content including algorithms for management of cardiovascular toxicities and one-view overviews of malignancies.Includes a comprehensive drug guide that provides quick reference to drugs prescribed for cancers with therapeutic indications, manifestations and mechanisms of cardiotoxicity, their risk factors, and risk reduction strategies.Brings you up to date with new immune therapies, including immune checkpoint inhibitors and CAR T-cell therapies Enhanced eBook version included with purchase. Your enhanced eBook allows you to access all of the text, figures, and references from the book on a variety of devices. Table of contents :-1. The Cardio-Oncology ClinicPart I. Cardiovascular Disease Management Before Cancer TreatmentSection A. The A-to-Z Before Therapy2. Key Points of Cardio-Oncology Evaluation Before Cancer Therapy3. Chemotherapeutic Risks Before Cancer Therapy4. Radiation Therapy Risks Before Cancer Therapy5. Bone Marrow Transplantation Risks Before Cancer Therapy6. Surgical Risks Before Cancer TherapySection B. Cardiovascular Disease Prevention in Cancer Patients7. Cardiomyopathy/Heart Failure Prevention Before Cancer Therapy8. Vascular Disease Prevention Before Cancer Therapy9. Thromboembolic Disease Prevention Before Cancer Therapy10. Arrhythmia Prevention and Device Management Before Cancer Therapy11. Hypertension and Renal Disease Prevention Before Cancer Therapy12. Pulmonary Disease Prevention Before Cancer Therapy13. Cardiopulmonary Exercise for Prevention Before Cancer TherapyPart II. Cardiovascular Disease Management During Cancer TreatmentSection C. The A-to-Z Through Therapy14. Key Points of Cardio-Oncology Evaluation During Cancer Therapy15. Cardiomyopathy/Heart Failure Myocarditis, and Takotsubo's During Cancer Therapy16. Structural Heart Disease17. Vascular Disease18. Thromboembolic Disease19. Arrhythmia, QTc Prolongation, and Device Management20. Hypertension and Renal Disease21. Pulmonary Disease22. Cardiovascular ImagingPart III. Cardiovascular Disease Management After Cancer TreatmentSection D. The A-to-Z After Therapy23. Key Points of Cardio-Oncology Evaluation After Cancer Therapy24. Cancer Survivorship and Co-Morbidity Disease Risk25. Long-Term Complications of Chemotherapy26. Long-Term Complications of Radiation TherapySection E. Cardiovascular Disease in Cancer Survivors27. Cardiomyopathy/Heart Failure Prevention and Management28. Structureal Heart Disease Prevention and Management29. Vascular Disease Prevention and Management30. Thromboembolic Disease Prevention and Manageent31. Arrhythmia Prevention and Management32. Hypertension and Renal Failure Prevention and Management33. Pulmonary Disease Prevention and Management34. Cardiopulmonary RehabilitationSection F. Cardiovascular Disease Management in Specific Malignant Diseases35. Breast Cancer36. Uterine, Ovary, and Cervical Cancer37. Prostate and Testicular Cancer38. Renal and Urinary Bladder Cancer39. Lung Cancer40. Colorectal Cancer41. Esophageal and Gastric Cancer42. Hepatobiliary Carcinomas43. Pancreatic Cancer44. Melanoma45. Head-and-Neck Cancers46. Thyroid cancer47. Glioblastoma48. Bone and Soft Tissue Sarcomas49. Leukemias50. Lymphomas51. Multiple Myeloma and Cardiac Amyloidosis52. Carcinoid53. Cardiac MassesPart IV. Cancer Drugs54. Cancer Therapeutic Drug Guide